Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.120
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.130
+0.010 (0.89%)
After-hours: Mar 9, 2026, 4:30 PM EDT
Bionano Genomics Employees
As of December 31, 2024, Bionano Genomics had 100 total employees, including 98 full-time and 2 part-time employees. The number of employees decreased by 244 or -70.93% compared to the previous year.
Employees
100
Change (1Y)
-244
Growth (1Y)
-70.93%
Revenue / Employee
$287,200
Profits / Employee
-$385,870
Market Cap
11.40M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 355 |
| Jin Medical International | 273 |
| Retractable Technologies | 227 |
| Precision Optics Corporation | 90 |
| Femasys | 71 |
| Ekso Bionics Holdings | 55 |
| Nephros | 31 |
| NEXGEL | 19 |
BNGO News
- 1 hour ago - Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 - GlobeNewsWire
- 10 days ago - Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale - GlobeNewsWire
- 11 days ago - 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders - GlobeNewsWire
- 12 days ago - 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy - GlobeNewsWire
- 13 days ago - 9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies - GlobeNewsWire
- 4 weeks ago - Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping - GlobeNewsWire
- 4 weeks ago - Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies - GlobeNewsWire
- 3 months ago - Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies - GlobeNewsWire